Search Results - "Takada, Akitsugu"
-
1
Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects
Published in Clinical pharmacology in drug development (01-04-2019)“…Roxadustat is a hypoxia‐inducible factor prolyl hydroxylase inhibitor in late‐stage clinical development for the treatment of anemia in chronic kidney disease…”
Get full text
Journal Article -
2
Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies
Published in Advances in therapy (01-12-2017)“…Introduction Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella–zoster virus infections. In this article…”
Get full text
Journal Article -
3
A phase I, open-label, single-dose micro tracer mass balance study of 14C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry
Published in Drug metabolism and pharmacokinetics (01-04-2018)“…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
Get full text
Journal Article -
4
A phase I, open-label, single-dose micro tracer mass balance study of 14 C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry
Published in Drug metabolism and pharmacokinetics (01-04-2018)“…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
Get full text
Journal Article -
5
Integrative pharmacokinetic–pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes
Published in Drug metabolism and pharmacokinetics (01-08-2016)“…Amenamevir is a novel drug that targets the viral helicase–primase complex. While dose-dependent efficacy had been observed in non-clinical studies, no clear…”
Get full text
Journal Article -
6
The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies
Published in Advances in therapy (01-12-2017)“…Introduction Amenamevir (ASP2151) is a nonnucleoside human herpesvirus helicase-primase inhibitor that was approved in Japan for the treatment of herpes zoster…”
Get full text
Journal Article -
7
Population pharmacokinetics of roxadustat in Japanese dialysis‐dependent chronic kidney disease patients with anaemia
Published in British journal of clinical pharmacology (01-02-2022)“…Aims Our objective was to develop a population pharmacokinetic (PK) model to describe roxadustat plasma concentrations in Japanese dialysis‐dependent chronic…”
Get full text
Journal Article -
8
Pharmacokinetic/pharmacodynamic modeling of roxadustat's effect on LDL cholesterol in patients in Japan with dialysis-dependent chronic kidney disease and anemia
Published in Drug metabolism and pharmacokinetics (01-10-2022)“…The objective of this analysis was to develop and evaluate a pharmacokinetic/pharmacodynamic (PK/PD) model of the effect of roxadustat on low-density…”
Get full text
Journal Article -
9
Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression
Published in Clinical therapeutics (01-06-2020)“…The objectives of this study were to explore covariates of plasma quetiapine concentrations after oral administration of quetiapine extended-release…”
Get full text
Journal Article -
10
Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder
Published in Clinical therapeutics (01-08-2020)“…Quetiapine has been reported to prolong the QT interval, and has been used as a positive control in thorough QT studies. The objective of the present study was…”
Get full text
Journal Article -
11
Quantification of ASP2151 in Human Plasma and Urine: A Pitfall Associated with Supersaturation of Analyte in Urine
Published in Chromatographia (01-02-2017)“…This is a case study of the difficulties caused by supersaturation of an analyte during the quantification of a drug in urine. To support the clinical…”
Get full text
Journal Article -
12
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
Published in The Pediatric infectious disease journal (01-05-2009)“…BACKGROUND:Determining the safety and pharmacokinetics of antifungal agents in neonates is important. A previous single-dose pharmacokinetic study of…”
Get full text
Journal Article -
13
Population pharmacokinetic modeling of Sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma
Published in Investigational new drugs (01-04-2013)“…Summary Purpose Population pharmacokinetics (PK) of sepantronium bromide (YM155) was characterized in patients with non-small cell lung cancer, hormone…”
Get full text
Journal Article -
14
Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults
Published in Advances in therapy (01-11-2017)“…Introduction Amenamevir is a nonnucleoside antiherpes virus compound available for treating herpes zoster infections. Four studies aimed to determine any…”
Get full text
Journal Article -
15
PK–PD modeling of 1-(3- C-ethynyl-β- d- ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes
Published in International journal of pharmaceutics (30-07-2009)“…The efficacy of an antitumor nucleoside, 1-(3- C-ethynyl-β- d- ribo-pentofuranosyl)cytosine (3′-ethynylcytidine, ECyd), was analyzed in vitro and in vivo. The…”
Get full text
Journal Article -
16
An Open‐Label, Single‐Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults
Published in Clinical pharmacology in drug development (01-07-2019)“…Amenamevir is an inhibitor of the helicase‐primase enzyme complex developed for the treatment of varicella zoster virus. This mass balance study investigated…”
Get full text
Journal Article -
17
Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes
Published in Clinical pharmacology in drug development (01-09-2014)“…Amenamevir is the international non‐proprietary name for ASP2151 synthesized by Astellas Pharma, Inc. It is a structurally novel class of helicase‐primase…”
Get full text
Journal Article